Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06274723
Other study ID # STUDY00001220
Secondary ID 1K99CA281094-01A
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2024
Est. completion date December 31, 2024

Study information

Verified date June 2024
Source University of Massachusetts, Worcester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 800
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria: - US residents ages 18-24 - Fluent in English - Reporting either vaping in the past 30 days or not having vaped in the past 30 days but susceptible to vaping Exclusion Criteria: - Age less than 18 or above 24 - Not fluent in English - Not a member of partnering crowdsourcing behavioral research platform conducting the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Expert
Participants will view a brief description of an expert source.
Peer
Participants will view a brief description of a peer source.
1 Sided
Participants will view e-cigarette education messages in one-sided.
2 Sided
Participants will view e-cigarette education messages in two-sided.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Massachusetts, Worcester National Cancer Institute (NCI)

Outcome

Type Measure Description Time frame Safety issue
Primary Message acceptance Message acceptance will be measured by five-item perceived message effectiveness questionnaire, such as the extent to which the message was worth remembering, grabbed their attention, powerful, convincing, and meaningful on a scale from 1 (Strongly disagree) to 5 (Strongly agree). 20 minutes
Primary Harm perceptions Harm perceptions will be measured by four-item e-cigarette harm perceptions questionnaire, such as the extent to which vaping is safe, contain flavors that are safe to use, contain dangerous chemicals, and harmful to health on a scale from 1 (Strongly disagree) to 5 (Strongly agree). 20 minutes
Secondary Psychological reactance Psychological reactance will be measured by six-item reactance questionnaire, such as perceptions of messages being manipulative, misleading, distorted, overblown, exaggerated, and overstated on a scale from 1 (Strongly disagree) to 5 (Strongly agree), and a four-item anger scale, measuring the extent to which the messages made participants feel irritated, angry, annoyed, and aggravated on a scale from 1 (not at all) to 5 (very much). 20 minutes
Secondary Message liking Message liking will be measured by a single-item liking of the message on scale from 1 (Dislike very much) to 5 (Like very much). 20 minutes
Secondary Source trust Source trust will be measured by a single-item trust in health information source questionnaire, such as trust in source about vaping information on a scale from 1(Not at all) to 5 (Very much so). 20 minutes
Secondary Attitudes Attitudes will be measured by seven-item vaping attitudes questionnaire, such as vaping is unenjoyable/enjoyable, unhealthy/healthy, dangerous/safe, boring/fun, stupid/smart, not cool/cool, and not attractive/attractive on a five-point bipolar scale. 20 minutes
Secondary Behavioral intentions to vape or try vaping Behavioral intentions to vape will be measured by a three-item behavioral intentions questionnaire, such as intentions to vape (for vapers)/try vaping (for non-vapers) soon, anytime during the next year, would use offered by one of their best friends on a scale from 1 (Definitely not) to 5 (Definitely yes). 20 minutes
See also
  Status Clinical Trial Phase
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Recruiting NCT05454267 - Early Detection of Vaping-related Vascular Diseases
Enrolling by invitation NCT04678245 - Network Intervention to Prevent Vaping N/A
Recruiting NCT06297005 - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Completed NCT04522362 - Modeling Stress-precipitated Vaping Behavior N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Recruiting NCT06291597 - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting NCT04919590 - Text Message Quit Vaping Intervention for Adolescents N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT04707911 - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents N/A
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06335329 - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping N/A
Completed NCT06433466 - Influencer Marketing: a Survey-based Experiment N/A
Active, not recruiting NCT05488743 - Smoking Prevention Program in Poland
Terminated NCT05240027 - To Vape or Not to Vape N/A
Recruiting NCT04661683 - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol N/A
Completed NCT04450537 - PACE Vape Messaging Study N/A
Active, not recruiting NCT05367492 - Varenicline for Nicotine Vaping Cessation in Adolescents Phase 4
Completed NCT04879225 - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study N/A